The present invention relates to a carbon nanohorn aggregate encapsulating a substance such as fine particles therein and a process for producing the same.
Recently, it has been studied to use various inorganic substances or organic substances as a carrier for a drug in drug delivery systems (DDS). With the rapid development of nanotechnology, nanoparticles have attracted particular attention as such a carrier and a number of reports have been made so far.
Under such circumstances, nano carbon materials of nano size including carbon nanotubes and carbon nanohorns have received increasing attention, and attempts have been made to modify such nano carbon materials so as to give them functions such as biocompatibility and medicinal properties in addition to properties resulting from characteristic structures of nano size substances.
For example, Patent Document 1 focuses on specific structures of carbon nanohorns and discloses a technique relating to a novel aggregate and a process for producing the same, in which a functional molecule having a physiological or pharmacological activity is introduced into the sheath of nanohorns. Also, Non-Patent Document 1 describes that since the above-described carbon nanohorn aggregate into which a drug is introduced has sustained release properties and the substance in the aggregate has a pharmacological activity, the aggregate can be applied to a drug delivery system (DDS) drug.
Further, Patent Document 2 reports an application using a carbon nanohorn as a carrier for a contrast medium in MRI and provides a contrast medium which satisfies the requirement of low toxicity, realizes diagnosis in small areas and can be easily synthesized in large amounts by supporting Fe or Gd therein.
Also, Patent Document 3 reports that after encapsulating metal fine particles in a carbon nanohorn aggregate having an opening therein, the opening is closed so as to prevent elution of fine particles of metal or the like in the body.
In such a contrast medium for MRI as disclosed in Patent Document 2, the sheath of nanohorns remains open although the substance having a contrast effect is supported in the nanohorns, and therefore the substance having a contrast effect has come into contact with the surroundings in some cases. As a result, the elution or the change of properties of the substance in the body has been a major problem in practical use.
Also, in the carbon nanohorn aggregate encapsulating metal fine particles disclosed in Patent Document 3, the encapsulated metal fine particles are present in the region near the tip of nanohorns, and therefore generally the fine particles have a diameter of about 2 nm. In that case, ferromagnetism is not satisfactorily exhibited even though metal which exhibits ferromagnetism such as Fe is encapsulated, and thus a problem is that, for example, transferring carbon nanohorns to the intended position from the outside of the body using a magnet, in other words, targeting, is impossible. Moreover, since encapsulated fine particles are dispersed in the tip of the sheath of carbon nanohorns in nanosize, another problem is that no sufficient contrast effect can be expected when used as a contrast medium.
The present invention has been made under the above circumstances and a first object of the present invention is to provide a substance-encapsulating carbon nanohorn aggregate in which the encapsulated substance is isolated from outside and which has high chemical stability without causing elution or the like in an environment such as the body, and a process for producing the same.
A second object of the present invention is to provide a substance-encapsulating carbon nanohorn aggregate which is useful as a targeting material which can be led from outside of the body or as a contrast medium, by allowing the dispersed encapsulated substance to be held in an aggregated form, and a process for producing the same.
To solve the above problems, the present invention has the following characteristics.
Specifically, in the substance-encapsulating carbon nanohorn aggregate according to the present invention, a functional material such as metal is encapsulated in a carbon nanohorn having an opening formed by oxidization, and with closing the opening by a heat treatment using surrounding impurity carbon or by self deformation, the encapsulated substance is aggregated and stabilized in the central part of the carbon nanohorn aggregate.
According to the invention of this application, even when encapsulating a substance which dissolves away or causes reaction under conditions such as the body, the encapsulated substance is isolated from outside. On the other hand, since chemically stable carbon nanohorns come into direct contact with external environment, the aggregate is stable even in an acidic atmosphere or the like. For that reason, the substance-encapsulating carbon nanohorn aggregate of the present invention has high stability against oxidation, corrosion or dissolution. Also, the encapsulated metal is not oxidized and is stable even in an oxidative atmosphere.
Further, since the encapsulated substance has a size of about 5 to 50 nm in an environment isolated from outside, the substance-encapsulating carbon nanohorn aggregate according to the present invention is most suitable for improving effects of contrast medium or for application to targeting in DDS utilizing magnetization or the like.
The invention of this application has the characteristics as described above. An exemplary embodiment thereof will be described below.
In the process for preparing the substance-encapsulating carbon nanohorn aggregate according to the present invention, first an oxidation treatment for preparing a carbon nanohorn having an opening formed by oxidization is carried out as shown in
The carbon nanohorn used as a starting material is an aggregate of carbon nanohorns each of which has a diameter of 2 to 5 nm and which are aggregated in a spherical form with the tips of the horns directed outward. Aggregates having a diameter of 30 to 200 nm can be used. When forming a small opening in the carbon nanohorn, the size of the opening can be controlled by various oxidation conditions. In the oxidation by a heat treatment in an oxygen atmosphere, the size of the opening in carbon nanohorns can be controlled by changing the temperature of the oxidation treatment. An opening having a diameter of 0.3 to 1 nm can be formed at 350 to 550° C. Also, an opening can be formed by treatment with acid or the like as described in Japanese Patent Laid-Open No. 2003-95624. An opening of 1 nm can be formed with a nitric acid solution at 110° C. in 15 minutes and an opening of 1 nm can be formed with hydrogen peroxide at 100° C. in 2 hours. By changing the diameter of openings by controlling the condition of forming openings, the amount (size) of the encapsulation substance incorporated into the inside of carbon nanohorns can be controlled. As described later, the amount of the encapsulation substance incorporated into the inside of carbon nanohorns can also be controlled by changing the condition of incorporating the encapsulation substance. As described above, controlling the amount of the encapsulation substance incorporated into the inside of carbon nanohorns allows to control the size of the encapsulated substance held in the carbon nanohorns, and further the size of the substance encapsulated in the central part of the carbon nanohorns after heat treatment.
By a heat treatment in vacuum, inert gas, hydrogen or in a combination thereof, the encapsulated substance is transferred to the central part and aggregated. In this case, the heat treatment temperature is preferably in the range of room temperature to 1800° C. It is desirable that the temperature of heating is appropriately controlled to a temperature near the melting point of the encapsulated substance. Also, the encapsulated substance can be transferred at the evaporation temperature of the encapsulated substance depending on the type of the encapsulated substance. A temperature of 1800° C. or higher is not preferable because graphitization of carbon nanohorn tends to occur. The inert gas is preferably nitrogen, argon, helium or neon. Further, the encapsulated substance can also be transferred with being reduced by hydrogen or the like.
Substances to be encapsulated in carbon nanohorns having an opening formed by oxidization are not particularly limited, and intended substances include those which are sublimated in vacuum or inert gas or dissolved in a solvent to exist in a solution when introducing the encapsulation substance in the process for producing a substance-encapsulating carbon nanohorn aggregate of the present invention. Any one of an organic substance, an inorganic substance and a metal, or a mixture of two or more of them can be used as long as they are substances as described above. When a plurality of substances is encapsulated, the chemical reaction between the substances results in the intended properties, for example, catalytic properties. In that case, the composition of the encapsulation substance can be controlled by controlling the mixing ratio of substances to be encapsulated. Alternatively, when a plurality of substances is encapsulated, each substance can be designed to function as a different catalyst.
Although types of substances encapsulated in the substance-encapsulating carbon nanohorn aggregate in the invention of this application are not particularly limited, a paramagnetic metal or ferromagnetic metal can be used as metal in particular. As such a metal, a rare earth metal selected from Gd, Ce, Pr, Sm, Eu, Tb, Dy, Er, Ho, Tm and Yb, a single metal selected from Mn, Fe, Ni, Co, Ru, Rh, Pt and Pd and an alloy thereof can be used. Of them, Gd is particularly preferable in terms of contrast effects. Also, as a ferromagnetic metal, a single metal of Fe, Ni and Co and an alloy thereof can be used, and Fe is particularly desirable in terms of contrast effects or as a material for targeting from the outside of the body using a magnet. Oxides of the above metals are preferred as inorganic substances, and organic functional substances such as fullerene, metal-encapsulated fullerene, dexamethasone (DEX), doxorubicin (DRX), tetrathiafulvalen (TTF) and tetracyanoquinodimethane (TCNQ) and metal aggregates such as ferrocene, phthalocyanine and cisplatin are preferably used as organic substances. The pressure of the atmosphere for introducing those substances is preferably 1 atm or less in a gas phase, and the size and the amount can be controlled by changing the amount, the temperature or the time of introduction. The amount of introduction is preferably up to about 60% by weight. The temperature upon the introduction is preferably room temperature to about 1800° C. and the time of the introduction can be up to about 48 hours. In a liquid phase, the size and the amount of the substance to be introduced can be controlled by changing solvents, the pH or the concentration in a solution, temperature or time. In that case, concentrations up to the saturated concentration in each solvent can be employed and the temperature is preferably room temperature to about 300° C. and the time can be up to about 200 hours.
By subjecting to a heat treatment in vacuum, inert gas or a reducing atmosphere after introducing various encapsulated substances as described above, the substance initially introduced is transferred to the central part. When the temperature is 800 to 1800° C. at that time, nano openings formed by the opening treatment can be closed. At this stage, some of the encapsulated substance is transferred to the tip of nanohorns as well because of the high stability resulting from the large contact area with the sheath of the nanohorns.
Also, the substance-encapsulating carbon nanohorn aggregate described above is characterized in that the encapsulation substance incorporated therein can be any one of a metal, an inorganic substance and an organic substance, a mixture of two or more of them, or a compound thereof. A metal such as Gd, Fe or lanthanoid or an oxide thereof is particularly effective for a contrast medium.
For the substance-encapsulating carbon nanohorn aggregate described above, a petal-like graphene sheet-containing carbon nanohorn aggregate (petal-containing carbon nanohorn aggregate), a dahlia-shaped carbon nanohorn aggregate, a bud-shaped carbon nanohorn aggregate or a seed-shaped carbon nanohorn aggregate can be used. Herein, the petal means a structure of 1 to 10 layers of stacked graphenes, having length and width dimensions of about 30 nm to 200 nm.
In the substance-encapsulating carbon nanohorn aggregate described above, the encapsulated substance is aggregated in the central part by a heat treatment and then substitution with a hydrophilic group can be done by another oxidation treatment. In the carbon nanohorn aggregate having an opening therein, a hydrophilic group can be attached to the edge of the opening. Examples of hydrophilic groups for the substitution include a carbonyl group, a carboxyl group and a hydroxyl group, but are not limited thereto. Also, addition of an organic substance or a biologically-relevant molecule to the hydrophilic group attached to the edge of the opening can offer properties such as solvent dispersibility and biological affinity.
The substance-encapsulating carbon nanohorn aggregate described above is characterized in that the incorporated encapsulated substance is preferably transferred through a tubular sheath when transferred by a heat treatment or the like.
The process for producing a substance-encapsulating carbon nanohorn aggregate according to the present invention includes aggregating the substance to be encapsulated in the central part or the neighborhood thereof by a heat treatment. A closing treatment of a carbon nanohorn aggregate having an opening therein can be simultaneously performed by the heat treatment as described above.
Next, exemplary embodiments of the present invention will be described but the present invention is not limited to these exemplary embodiments.
For the opening treatment of carbon nanohorns (CNH) (
(Evaluation of Substance-Encapsulating Carbon Nanohorn Aggregate) Nitrogen adsorption of CNH, oxCNH, Gd@oxCNH and HTGd@oxCNH was measured at 77 K by ASAP2000.
The HTGd@oxCNH in which openings are closed and the HTGdCNH were stirred in a 5 M hydrochloric acid solution for 24 hours. Thereafter the resultant was sufficiently washed with water using a filter. These procedures were performed 3 times. Whether Gd has been eluted from the collected samples or not was examined.
HTGd@oxCNH (40 mg) was dispersed in 100 ml of a hydrogen peroxide solution to perform an oxidation treatment at room temperature for 6 hours. Subsequently, hydrogen peroxide was rinsed off using a filter and the resultant was dried in vacuum. The resulting sample was then subjected to thermogravimetric analysis in He. The analysis was performed in a temperature range of room temperature to 600° C. at a temperature increase rate of 5° C./min. As a result, a weight reduction was observed at about 400° C., showing that about 1% of a surface functional group such as a carboxyl group was adsorbed. Polyethylene glycol (PEG) or the like was added thereto and the resultant was dispersed in phosphate buffered saline (PBS) to observe improvement in solvent affinity and biological affinity; as a result, while the carbon nanohorn aggregate without the above treatment was coagulated and sedimented, the hydrophilicity of the substance-encapsulating carbon nanohorn aggregate which has undergone the treatment has improved and no sedimentation was observed at all after 24 hours.
This application claims priority based on Japanese Patent Application No. 2007-247269 filed Sep. 25, 2007, which is hereby incorporated by reference in full.
Number | Date | Country | Kind |
---|---|---|---|
2007-247269 | Sep 2007 | JP | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/JP2008/060990 | 6/16/2008 | WO | 00 | 3/24/2010 |